AIM-102 Uses, Dosage, Side Effects and more
AIM-102 is under investigation in clinical trial NCT01501942 (Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma).
| Trade Name | AIM-102 |
| Generic | AIM-102 |
| Type | |
| Formula | C16H27N3O6 |
| Weight | Average: 357.407 Monoisotopic: 357.189985601 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
